https://www.novumpr.nl/2019/10/11/gilead-and-galapagos-announce-efficacy-and-safety-results-of-filgotinib-through-52-weeks-in-finch-1-and-finch-3-studies-in-rheumatoid-arthritis/?utm_source=rss&utm_medium=rss&utm_campaign=gilead-and-galapagos-announce-efficacy-and-safety-results-of-filgotinib-through-52-weeks-in-finch-1-and-finch-3-studies-in-rheumatoid-arthritis NovumPR press releases Fri, 11 Oct 2019 07:28:51 +0000 hourly 1 https://wordpress.org/?v=6.8.3